[1]
2024. Hubungan Kuantitatif Struktur-Aktivitas dan Desain Senyawa Novel PhenylBenzimidazoles sebagai Penghambat Wnt/β-Catenin untuk Terapi PancreaticDuctal Adenocarcinoma: Quantitative Structure-Activity Relationship and Design of Novel PhenylBenzimidazoles as Wnt/β-Catenin Inhibitors for Pancreatic DuctalAdenocarcinoma Therapy. Jurnal Sains dan Kesehatan. 5, 5 (Nov. 2024), 584–590. DOI:https://doi.org/10.30872/jsk.v5i5.438.